SFTPC and lung cancer: Furthermore, this potent derivative was also evaluated in vivo in a transgenic mouse lung cancer model expressing a mutated and constitutively active c-RAF kinase (c-RAF-1-BxB) under the control of the human surfactant protein C (SP-C) promoter in type II alveolar pneumocytes [28].